HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Triclosan Does Not Contribute To Antibacterial Resistance – Study

This article was originally published in The Tan Sheet

The Personal Care Products Council and the American Cleaning Institute tout a study they say confirms that consumer use of antimicrobial agents triclosan and triclocarbon does not lead to antibiotic or antibacterial resistance.

Published in the International Journal of Microbiology Research, the study funded by the two organizations pitted OTC antibacterial liquid body cleansers and antibacterial bar soaps against non-antibacterial cleansers, measuring their impact on Staphylococcus bacteria from subjects’ forearms and susceptibility to 10 antibiotics.

“There was no statistically significant difference in antibiotic resistance of Staphylococcus isolates obtained from the skin of regular antibacterial wash product users in comparison with non-antibacterial product users,” says lead investigator Eugene Cole, professor of environmental health sciences in Brigham Young University’s Department of Health Science.

There was also a “definitive” lack of antibiotic and antibacterial cross resistance among those bacteria, he notes.

According to an Oct. 4 release from the council and ACI, the study “discounts claims that use of antibacterial wash products have contributed to the selection and spread of drug-resistant bacteria on human skin.”

Study Focuses On Staphylococcus Bacteria

The study examined subjects in three categories – those who frequently use bath or shower products containing triclosan, frequently use bar soaps containing triclocarbon or do not use any antibacterial wash products.

Frequent users were defined as consumers who used triclosan- or triclocarbon-based products to wash their bodies on a regular basis during the 30 days prior to the study.

Study participants were selected randomly from a pool of 450 individuals – 70 for each of the three groups, for a total of 210 subjects.

Each subject was swabbed on both forearms for samples of Staphylococcus bacteria, which was then brought to a lab and tested against the 10 antibiotics often used to treat staph infections.

Staphylococcus was selected as the target bacteria indicator because of its “potential to develop antibiotic resistance and act as human pathogens,” according to the study.

Overall, among the subjects who frequently use antibacterial wash products containing triclosan/ triclocarbon, there was no increase in antibiotic resistance of staph strains compared those who do not use antibacterial wash products.

In testing coagulase-negative Staphylococcus from subjects for resistance to penicillin/methicillin, for example, data showed there was a statistically insignificant difference between triclosan product users and non-users. Among non-using participants, 17.9% showed methicillin resistance, while 23.5% of triclocarbon users and 20.4% of triclosan users showed resistance.

Among the subjects who frequently use antibacterial wash products, there was no increase in antibiotic resistance of staph strains compared with individuals who do not use antibacterial wash products.

In comparison, methicillin resistance rates were 43.6% for outpatients in a 1998-1999 study conducted at 23 U.S. hospitals.

Cole and his colleagues say they found no statistically significant differences across the drugs tested, with the exception of tetracycline, which showed resistance in the non-user group of 17%, comparatively higher than the combined triclosan/triclocarbon groups – 9.7%.

The researchers also found no bacteria from either group showed increased resistance to triclosan or triclocarbon.

Could Study Quell Triclosan Debate?

The study was conducted in part due to a call for research on the subject, as there has been “very limited evidence that there is a correlation between antibiotic and antibacterial agent resistance in community bacteria associated with humans,” the researchers write.

They also point out the study protocol and its methods were reviewed and approved by an independent institutional review board.

The study – titled “Investigation of Antibiotic and Antibacterial Susceptibility and Resistance in Staphylococcus from the Skin of Users and Non-Users of Antibacterial Wash Products in Home Environments” – comes during a contentious time for the ingredient.

While lawmakers and non-government organizations call for banning triclosan due to concerns about antibiotic resistance and the ingredient’s suspected role in endocrine disruption, industry argues that evidence supporting such risks is lacking.

House Democrats Louise M. Slaughter, N.Y., Betty McCollum, Minn., and Raul Grijalva, Ariz., asked for a triclosan ban in a November 2010 letter to FDA Commissioner Margaret Hamburg, and Ed Markey, D-Mass., also has encouraged FDA and the Environmental Protection Agency to outlaw the ingredient (Also see "FDA Should Ban Triclosan, House Democrats Urge" - Pink Sheet, 13 Dec, 2010.).

Meanwhile, in letters and petitions to federal agencies, the Environmental Working Group, Beyond Pesticides and Food & Water Watch also have come out against triclosan use.

The Campaign for Safe Cosmetics say companies are moving away from including triclosan in products, but suggests the ingredient still is used widely.

Industry maintains antibacterial products with triclosan are safe and effective.

Soon after Rep. Markey’s query to FDA and EPA, researchers, including a Colgate-Palmolive manager, published a study they say demonstrates the benefit of triclosan-containing toothpaste over fluoride-only products (Also see "Colgate Answers Markey With Study Backing Triclosan Benefit In Toothpaste" - Pink Sheet, 10 May, 2010.).

Francis Kruszewski, ACI’s director of human health and safety, characterizes the latest study as an extension of the hygiene industry’s research efforts to ensure product and ingredient efficacy and safety.

“This is part of our industry’s long-standing commitment to product stewardship,” he says. “After decades of use, antibacterial wash products continue to play a beneficial role in everyday hygiene routines for millions of people around the world.”

The council and ACI commissioned a survey earlier in 2011 on consumer attitudes regarding antibacterial soap. Two-thirds of the respondents said they would be “angry” if antibacterial soaps were taken off the market (Also see "People Rely On Antibacterial Soap, Would Be "Angry" If It Weren't Available" - HBW Insight, 24 Jan, 2011.).

The groups recently launched FightGermsNow.com, a website for “fact-based, meaningful information on antibacterial soaps and ingredients.”

The Cosmetic Ingredient Review Expert Panel reviewed triclosan in December 2010, determining the ingredient safe for use in cosmetics.

The panel limited its review to new data for triclosan in six areas – exposure, sourcing and dioxin impurities, photostability and dioxin photoproducts, carcinogenicity, endocrine disruption and potential for bacterial resistance (Also see "CIR Affirms Triclosan Safety, Opts For Formaldehyde Re-Review" - HBW Insight, 20 Dec, 2010.).

[Editor’s note: This story was contributed by “The Rose Sheet,” your source for cosmetics industry news. For more information call 1-800-332-2181.]

By Lauren Nardella

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel